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Introduction
In 1987, Cloninger proposed a systematic method for the 
clinical description and classification of different personality traits, 
based on the Biosocial Theory [1]. This theory is based on several 
neuropharmacological, neuroanatomical, neurophysiological and 
psychometric studies conducted on personality structure, that 
hypothesize a partition of temperament in three dimensions, genetically 
Abstract
Background: In 1987, Cloninger proposed a clinical description and classification of different personality traits 
genetically defined and independent from each other. Moreover, he elaborated a specific test the TCI to investigate 
these traits/states. The study of craving in Alcohol Use Disorder (AUD) assumed a greater significance, since ever more 
data seems to suggest a direct correlation between high levels of craving and a higher risk of relapse in alcoholics. Thus, 
our study aim is to explore the possible correlations among TCI linked molecular neurobiological pattern (s), craving and 
alcohol addiction severity measures in a sample of Italian alcoholics.
Materials and Methods: 191 alcoholics were recruited in a Day Hospital (DH) setting at the Alcohol Addiction 
Program Latium Region Referral Center, Sapienza University of Rome. After 7 days detoxification treatment a psycho-
diagnostic protocol was administered, including TCI, VAS-C, ASI and SADQ. All patients signed an Institutional Review 
Board (IRB) approved informed consent.
Results: Principally, we detected a significant positive correlation between HA-scale scores and the VAS scale: 
increasing in HA-scale corresponds to an increase in craving perception for both intensity (r=0.310; p ≤ 0.001) and 
frequency (r=0.246; p ≤ 0.001). Moreover, perception of dependence severity, measured with SADQ was also found to 
be significantly associated positively to both HA-scale (r=0.246; p ≤ 0.001) and NS-scale (r=0.224; p ≤ 0.01). While, for 
character scales, Persistence (r=-0.195; p=.008) and Self-directedness (r=-0.294; p ≤ 0.001) was negatively associated 
with ASI linked to alcohol problems. Self-directedness was also negatively correlated with ASI linked to family and 
social problems (r=-0.349; p ≤ 0.001), employment and support problems (r=-0.220; p=0.003) and psychiatric problems 
(r=-0.358; p ≤ 0.001). Cooperativeness was a negative correlate with Legal Problems (r=-0.173; p=0.019). and Self-
Transcendence was positive correlated with Medical Problems (r=0.276; p ≤ 0.001)
Conclusions: In view of recent addiction neurobiological theories, such as the “Reward Deficiency Syndrome 
(RDS)” and the Koob model, our data could suggest that our cohort of patients could possibly be in a particular stage of 
the course of their addiction history. Thus, if our hypothesis will be confirmed, the TCI-based assessment of alcoholics 
would allow an optimization of the treatment. Clinicians understanding these newer concepts will be able to translate 
this information to their patients and potentially enhance clinical outcome (s), because it could suggest a functional 
hypothesis of neurotransmitter circuits that helps to frame the patient in his/her history of addiction.
defined and independent from each other, respectively associated to the 
function of three neurotransmitters. These dimensions interact together 
in adaptive responses to specific environmental stimuli, building typical 
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personality traits/states [2,3]. These three temperament dimensions, 
described by Cloninger, are: Novelty Seeking, Harm Avoidance and 
Reward Dependence. The first one (NS – Novelty Seeking) notices the 
propensity to pronounced excitement in response to new stimuli; the 
second one (HA – Harm Avoidance) describes the propensity to avoid 
aversive stimuli acting strategies in order to prevent punishments. The 
last dimension (RD-Reward Dependence) related to impairments of 
the “brain reward cascade” leading to reward deficiency syndrome 
(RDS) and indicates the subject’s predominant reliance on external 
gratification, with a strong tendency of keeping positively supported 
behaviors and avoiding punishments. In the original view the NS is 
inversely related to the dopamine system, the RD is inversely related 
to the noradrenergic system while the HA is positively related with 
the serotonin system. However, with an emerging fields of Psychiatric 
Genetics and Genomics multiple genes are involved in all these 
behaviors and it is more complex [4]. 
Cloninger [1] has linked the combinations of these three 
temperamental index to several Personality Disorders (PD) described 
in DSM IV [5]. Moreover, Cloninger [1] developed a specific test 
that investigates those three described areas and four other factors 
(Persistence, Self-directedness, Cooperativeness, Self-Transcendence), 
non-correlated with specific neurotransmitters, but indicating 
some other behavioral peculiarities. Cloninger designed a self-
report questionnaire aimed to identify specific temperamental and 
behavioral patterns of the distinct population of patients. This tool, the 
Temperament and Character Inventory (TCI), in its original version 9, 
was composed by 240 items on a dichotomous scale (true–false) [6]. 
TCI was used in several pathological populations, including 
subjects with drugs and alcohol addiction [7,8]. Several studies have 
been published on the relationship between a number of particular 
personality traits and different types of alcoholism [8,9]. Cloninger 
proposed two types of alcoholism with distinctive clinical features and 
TCI profiles.
The Type I describes a kind of alcoholism with an onset of addiction 
over the age of 25, without familiarity or any important comorbidities. 
These patients score high on the HA and RD subset of the TCI. 
The Type II, clinically presents an early-onset of addiction patterns, 
with important familiarity and comorbidities (for example cluster B 
personality disorders, bipolar disorders etc.). Moreover, psychosocial 
problems could be associated these patients score high on both NS and 
HA subset of the TCI [9-22].
Craving in Alcohol Use Disorder (AUD)
“Craving” is a clinical concept, ambiguously definable. It can be 
explained as a set of cognitive, behavioral and physiological symptoms 
indicating the intense and uncontrollable desire of consuming a 
psychotropic substance, the effects of which have already been 
experienced [23]. It is well established that craving can be a strong 
predictor of relapse [24,25], and in the current classification of mental 
disorders (DSM-5), craving is one of the criteria for the diagnosis of 
addiction [26]. In substance abuse, craving is characterized by the 
presence of some key features, such as the strong attraction (impulsive 
and/or compulsive) to situations that allow the intake of substances and 
the behavioral activation, cognitive and emotive, featured by multiple 
sets of symptoms. Anton et al. [27] suggested that many traits of 
alcohol craving are similar to some clinical features of OCD (Obsessive 
– Compulsive Disorder) patients. They point out that craving may be 
linked to recurrent and persistent thoughts about alcohol; the subject’s 
inability to resist these thoughts; compulsive thrust to alcohol-intake; 
and loss of control [27]. Even if alcohol craving was traditionally 
conceptualized as a singular-dimensional condition [28], the modern 
view as espoused by the American Society of Addiction Medicine 
(ASAM) recently defined addiction as a complex brain disorder 
involving RDS [29,30] due to reward circuitry impairments. 
Moreover, contemporary theorists recognize nowadays a dynamic 
competition between the tendencies to approach drinking and the 
ones to avoid drinking [31]. Meanwhile, there was a growing emphasis 
about the distinction between a) craving as “entity”, i.e. the simple, 
unidirectional desire of drinking and b) this desire seen as a “process”, 
or a more complex experience that requires consideration of many 
contextual factors. Finally, there is a strong impetus to integrate the 
complexities of both “molecular neurogenetics” and “psychological 
processes” that seems to be important antecedents to substance related 
seeking behavior (e.g. craving) [32]. McEvoy et al. [33] compared three 
models of craving, which reflect the evolution of the theory from a) 
traditional uni-dimensional model to b) bi-dimensional model of 
“ambivalence [31].” and after all to c) a “neuroanatomical” model that 
adheres to the dimension of avoiding, and as such integrates it with 
the multiple brain processes involved in reward, obsessive-compulsive 
behaviors and inhibitory processes [33-35]. 
In terms of Alcohol Use Disorder (AUD) the singular concept of 
just craving as the reason for relapse takes on a more complex dynamic 
when one compares our earlier non-genetic view with our modern 
view. A brief review of the current literature would suggest that a more 
parsonomiuos view is that relapse is due to a direct correlation between 
high levels of craving and a higher risk of relapse in alcoholics [36-42] 
including dopaminergic genetic antecedents including epigenetics [43]. 
Thus, the aim of the present study is to investigate the possible 
correlations between TCI “phenomena” and putative molecular 
neurobiological antecedents, substance –related seeking and substance 
(i.e. alcohol) addiction severity indices in a sample of Italian alcoholics. 
Materials and Methods
Subjects 
The sample investigated consisted of 191 subjects (male n=133, 
female n=58; male average-age: 42.77 ± 9; female average-age: 41.78 ± 
7). Patients were eligible according to the following inclusion/exclusion 
criteria. Inclusion Criteria: 1) Signed informed consent form; 2) Age 
between 18 and 65 years old; 3) Italian native-speakers; 4) Diagnosis 
of alcohol abuse/dependence according DSM IV TR criteria; 5) 
Hospitalization in Day Hospital; 6) At least 7 days of alcohol abstinence. 
Exclusion Criteria: 1) Pregnant or lactating women; 2) Severe renal 
failure; 3) Decompensated liver cirrhosis; 4) Positive anamnesis for 
Deliberate Self-Harm (DSH); 5) Epilepsy; 6) Unstable or severe heart 
diseases; 7) Neoplastic Diseases.
All selected patients received a detoxification and rehabilitation 
integrated treatment in a hospitalization setting (Day Hospital, DH) 
at the Alcohol Addiction Program Latium Region Referrral Center, 
Sapienza University of Rome. The study was approved by the hospital’s 
IRB committee as well as the informed consent was signed by each 
participant. 
Study Protocol
The three study phases (alcohol detoxification, screening, psycho-
diagnostic assessment) are summarized in Table 1. 
Phase 1: Alcohol detoxification: During the first 7 days of the study 
alcohol detoxification was performed in the DH setting according to 
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the ‘symptom-triggered’ therapy. This therapy consists of monitoring 
patients and providing medication only when symptoms of alcohol 
withdrawal appear. The use of a simple, objective and standardized scale 
(Clinical Institute Withdrawal Assessment for Alcohol, revised Scale, 
CIWA) by the clinicians appears safe and effective in monitoring the 
patient’s clinical conditions. Usual prescriptions are for diazepam 20 mg 
orally (or chlordiazepoxide 100 mg orally) as needed hourly for a CIWA-
Ar score of >10. Nurses scored the patients at hourly intervals in early 
withdrawal. Drug doses are repeated until the appropriate therapeutic 
responses (suppression of symptoms of withdrawal) occurred [44]. 
Phase 2 Screening: Screening was performed at day 8 of the study 
according to the inclusion/exclusion criteria listed in Table 1.
Phase 3: Psycho-diagnostic assessment: Psycho-diagnostic 
assessment was performed between day 9 and 13 of the study to explore 
alcohol-related, cognitive and character dimensions of the subjects 
(Table 1)
AUD assessment: The ASI (Addiction Severity Index fifth edition) 
is a semi-structured weighted interview built with the purpose of 
gathering information about the patient’s life [45,46]. 
The Severity of Alcohol Dependence Questionnaire (SADQ) is a 
tool used to analyze the severity of the addiction through a series of 
symptoms referred to the maximum alcohol-abuse period [47,48]. 
The SADQ consist of a self-report questionnaire of 20 items with 0 
to 3 scores; this test evaluates the perceived frequency of physical and 
psychological symptoms of alcohol abuse. It is composed by a set of 
questions about some aspects of the dependency syndrome: withdrawal 
symptoms, affective symptoms, frequency of alcohol intake, and time to 
the onset of withdrawal symptoms.
The Visual Analogue Scale – Craving (VAS –C) uses a line of 
10 cm to measure the intensity and the frequency of the perceived 
craving for alcohol during the week before the admission in DH to 
Alcohol Addiction Program Latium Region Referrral Center, Sapienza 
University of Rome. In order to rate the intensity of the craving, 
subjects are asked to mark, on a scale of 1 to 10, whereby 1 indicate low 
desire and 10 indicates high desire to drink. For the frequency, subjects 
indicate how many times a day they feel their need to drink on a scale 
of 1 to 10 as well [49]. 
Cognitive assessment: The Mini Mental State Examination 
(MMSE) is an early screening test designed to detect early cognitive 
impairment, which has been correlated with electrophysiological 
measures to predict severity [50,51]. 
The Wechsler Adult Intelligent Scale (WAIS -R battery) provides 
information regarding the presence of learning difficulties due to 
previous to the alcohol abuse [52,53]. 
Temperament and character assessment: To assess personality 
traits (temperament and character) we used the version 9 of TCI test 
[22] (Italian translation by Battaglia and colleagues) [54]. 
Data Analysis
Statistical analyses described in this section were performed by 
SPSS version 13 for Windows package. A preliminary inspection of the 
distributional properties of the measures was conducted. Normality 
was tested on the outcome variables which were considered normally 
distributed. If skewness and kurtosis were found these variables were 
transformed with a logarithmic transformation. Pearson correlation 
coefficients were computed for evaluating relationships across the 
continuous variables considered. For the TCI scales the raw scores were 
used. In order to control Type1 error, Bonferroni correction was used 
and the significance level was set at .025.
Results
Descriptive statistics for the different measures in the full sample 
are summarized in Figure 1. In our sample 81.6% of the subjects also 
smoked cigarettes (mean ± SD per day 17.35 ± 10.92). Since Pearson 
correlations were used to perform data analysis, the smoking history 
was not used as a covariate variable. 
Utilizing TCI temperamental scales in our sample we detected a 
significant positive correlation between HA-scale scores and the VAS 
scale: increasing in HA-scale corresponds to an increase in craving 
perception for intensity (r=0.310; p ≤ 0.001) and frequency (r=0.246; p 
≤ 0.001). Moreover, perception of dependence severity, measured with 
SADQ was also found to be significantly associated positively to both 
HA-scale (r=0.246; p ≤ 0.001) and NS-scale (r=0.224; p ≤ 0.01). As of 
behavioral TCI scales our data show a significant negative correlation 
Study Phase 1 2 3
Days From 0 to 7 8 From 9 to 13
Interventions Alcohol Detoxification*
Screening** PSYCHODIAGNOSTIC ASSESSMENTAUD Assessment: ASI, SADQ,VAS-C, DRIE, OCDS
Cognitive Assessment: MMSE, WAIS-R
Character Assessment: TCI
*According to Lejoyeux et al. [44]
**According to the inclusion/exclusion criteria
Table 1: Study phases.
MEASURE Visual Analogic Scale-CravingIntensity
Visual Analogic Scale-Craving
Frequency
Severity of Alcohol Dependence
Questionnaire
TCI – Novelty Seeking .038 .029 .224**
TCI – Harm Avoidance .310*** .246*** .246***
TCI – Reward Dependence .035 -.007 .113
TCI – Persistence -.099 -.001 -.080
TCI – Self Directedness -.236** -.244** -.295***
TCI – Cooperativeness -.102 -.141 -.156*
TCI – Self Trascendence .026 .128 .078
Note: VAS measures in cm, SADQ total score; TCI raw scores and ASI composite scores 
*p < 0.05; ** p < 0.01; ***p < 0.001
Table 2:  Pearson correlations between TCI, VAS-Craving and SADQ
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between SD-scale and the VAS scale for craving frequency (r=-0.236; 
p ≤ 0.01) and intensity (r=-0.244; p ≤ 0.01). Lastly, significant negative 
correlations were observed between SADQ scores and SD-scale (r=-
0.295; p ≤ 0.001) and Cooperativeness (r=-0.156; p ≤ 0.01) (Table 2).
Pearson correlations between TCI temperament scales (HA, NS, 
RD) and dependence severity measured with ASI were not significant. 
(The ASI subscales reported in Table 3 are composite scores). For TCI 
character scales, Persistence was negative and significantly associated 
(r=-0.195; p=.008) with ASI linked to alcohol problems. Self-directedness 
was negative and significantly correlated with ASI linked to alcohol 
problems (r=-0.294; p ≤ 0.001), family and social problems (r=-0.349; 
p ≤ 0.001), employment and support problems (r=-0.220; p=0.003) 
and psychiatric problems (r=-0.358; p ≤ 0.001). Cooperativeness was a 
negative and weakly significant correlate with Legal Problems (r=-0.173; 
p=0.019). However, Self-Transcendence was positive and significantly 
correlated with Medical Problems (r=0.276; p ≤ 0.001) (Table 3).
Discussion
While we did not find a significant cognitive impairment among 
our studied sample, the overall data resulting from scores of character 
scales seem to confirm those already observed in the scientific literature 
[22]. The significant differences between TCI-SADQ and TCI-ASI 
pattern correlations may be due to multi –factorial elements including 
possible psychiatric comorbidities (non-detected in this study) [55]. 
However, we did find that addiction severity, assessed with the SADQ, 
is positively correlated with both Novelty Seeking and Harm Avoidance. 
Finally, in the same sample, perceived craving intensity is positively 
correlated with high scores in the HA scale but not for the NS scale. 
These results are in agreement with previous work by Blum et al. [56] 
showing the association of the DRD2 A1 allele and schizoid/avoidance 
behavior. 
The critical role of VTA dopamine in the regulation of affective and 
cognitive functions, in craving and reward has been well established 
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Figure 1: Descriptive statistics for thedifferent measures in the full sample: mean and standard deviation are reported for TCI raw scores scales in panel a); VAS 
Craving in panel b); severity measures SADQ total score and ASI Scales in panel c).
     MEASURE
ASI- Alcohol 
Problems
ASI- Drug 
Problems
ASI- Family/
Social Problems
ASI- Employment/
Support Problems
ASI- Legal 
Problems
ASI- Medical 
Problems
ASI- Psychiatric 
Problems
TCI – Novelty Seeking .034 -.047 .084 .015 .142 -.051 .042
TCI – Harm Avoidance .059 -.126 -.028 .031 .070 .053 -.048
TCI – Reward Dependence .054 .021 -.012 .064 .009 .087 -.076
TCI – Persistence -.195** .010 -.121 -.009 .104 -.034 -.118
TCI – Self Directedness -.294*** -.105 -.349*** -.220** -.103 -.109 -.358***
TCI Cooperativeness -.057 -.097 -.122 -.102 -.173* .033 -.130
TCI – Self Transcendence -.046 -.106 .042 .044 -.037 .276*** .055
*p < 0.05; ** p < 0.01; ***p < 0.001
Table 3: Pearson correlations between TCI and ASI.
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[55,56]. In fact, it is well established that there is a genetic vulnerability 
(the DRD2 Taq1 and the DAT1 9/9 allele carriers) within the critical 
system of the “Brain Reward Cascade” leading to the Reward Deficiency 
Syndrome [57,58]. 
Limitations
We are aware that significant limitations related to sample size, 
utilization of screened control comparison, and eventual psychiatric 
comorbidities may influence this research, but a possible explanation 
can be offered by recent scientific contributions from Koob and Volkow, 
with regards to the neurobiological bases of addiction [59].
Koob-Volkow Anti-Reward Model 
Koob and Volkow proposed a neurobiological pattern of addiction, 
composed of three phases: binge/intoxication, withdrawal/negative 
effect and preoccupation/anticipation. Impulsiveness often controls the 
early phases of this cycle, while both impulsiveness and compulsiveness 
characterize later phases. Neurobiological circuits seem to underlie 
each phase of the cycle: in the first one an important role is played 
by both ventral tegmental area and ventral striatum in which the 
enhancement of dopaminergic firing is primary; the amygdale has a 
key role in the second phase, while in the third one seems to be involved 
in a widely distributed network, formed by orbitofrontal cortex, dorsal 
striatum, prefrontal cortex, basolateral amygdale, hippocampus, insula 
and cingulated. In this circuit, the glutamatergic system appears to have 
an important role [59].
Transition to addiction involves neuroplastic mechanisms in all 
these structures; this process can begin with primary changes in the 
mesolimbic dopaminergic system and also changes of function in the 
prefrontal cortex in which seems to display an important role related to 
glutamatergic hyperfunction and relapse [59]. 
Recent findings, indeed, seem to further elucidate any of these 
neuroplastic mechanisms underlying an important homeostatic 
relationship between different brain reward neurotransmitters. For 
example, addictive drugs (“hijackers” of the reward homeostasis) seems 
to critically enhance the shift from tonic to phasic dopamine release 
in VTA; data seem to suggest an important VTA dopamine neuronal 
co-release of dopamine and glutamate; data show the critical role of 
“phasic dopamine” within the prefrontal cortex; evidence as pointed 
out by Koob & Volkow [59], suggest the possible critical role of DRD2 
receptors in sustaining the dopamine neurotransmission within the 
prefrontal cortex and volume of brain white matter as compromised 
with the presence of the DRD2 A1allele. In contrast, others [60-66] and 
Volkow et al. [67] have correctly suggested a possible protective role of 
DRD2-Taq A2 allele in the vulnerability to addiction. Finally, data seem 
to suggest a possible correlation between the dysfunction of the DRD2 
Taq A1 allele and schizoid/avoidant behavior [56,68,69] suggesting an 
important link between the dopaminergic system and Harm Avoidance 
behavior. Taking together the data and the theories above mentioned 
could suggest our cohort of patients could be in a particulate stage of the 
course of their addiction history characterized by a hyperglutamatergic 
state associated with a hypodopaminergic trait and or state. 
Exemplifying, alcoholics begin to drink to increase pleasure states 
; then they may subsequently drink in order to relieve the discomfort 
of so called “mini withdrawal “ due to lack of alcohol intake. At this 
stage dependence has already set in and both genetic antecedents 
and neuro-adaptation in the entire “brain reward cascade” dominates 
the inner brain dysfunction of the patient [56] with particular 
emphasis on the complex interaction between hypodopaminergic and 
hyperglutaminergic interaction [55]. 
Our finding showing the relationship between TCI and HA in Italian 
alcoholics may further assist in identifying future therapeutic targets. 
Based on recent genetic studies from our laboratory Blum et al. [57,70] 
show the importance of D2 agonistic therapy in hypodopaminergic 
traits. We are cognizant that upstream neurotransmitter deficits in 
serotonergic, endorphinergic and glutamatergic systems [71] represent 
additional therapeutic loci. However, we propose herein, that fixing the 
hypodopaminergic trait/state seems parsimonious. Importantly, De 
Bartolomeis [72] discussed the interaction of these neurotransmitters 
emphasizing the role of glutamatergic hyperactivity “links to” a 
serotoninergic hyperfunction. In consideration of prevention of relapse, 
we must not only target VTA dopaminergic activity but enhance, 
for example, cingulate gyrus induced decision making due to poor 
executive functions [73]. In fact, we have already shown the benefit of 
a putative natural D2 agonist known as KB220Z on increasing alpha 
and low beta activity at the cingulate gyrus utilizing qEEG analysis 
promoting a significant reduction of relapse [74].
Conclusion
In agreement with the extensive literature the TCI-based assessment 
of alcoholic patients enables early identification of their critical 
temperamental factors. Clinical utilization of these assessments allow 
for an optimization of treatment in terms of providing better targets 
that may translate to improved appropriateness and effectiveness. 
Our findings also suggest that clinicians should embrace these 
outlined hypotheses so that they could provide patients with a more 
comprehensive personalized analysis of AUD patients. In our opinion, 
discussing these newer concepts with RDS patients (AUD subset) 
will clinically assist the patients understanding and could suggest a 
functional hypothesis of neurotransmitter circuits that helps to frame 
the patient in his/her history of addiction. 
This concept is underscored by the importance of a prescreening 
tool known as Genetic Addiction Risk Score (GARS) that will provide a 
mirror to the polymorphic gene characteristics of AUD subjects. In fact 
this has already been shown to be beneficial in a clinical setting [75-77]. 
Based on our results, we suggest required additional research 
comparing the TCI and other neurophysiological measures including 
evoked potentials such as P300 with GARS to more definitively dissect 
important treatment targets. 
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